| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745793 | Parkinsonism & Related Disorders | 2013 | 6 Pages |
Abstract
Doxepin and non-pharmacologic treatment substantially improved insomnia in Parkinson's disease. These potential benefits must be replicated in a full confirmatory randomized controlled trial.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
S. Rios Romenets, L. Creti, C. Fichten, S. Bailes, E. Libman, A. Pelletier, R.B. Postuma,